Manufacturer record
Naprod Life Science Pvt. Ltd: regulatory record
Last checked 3 November 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories
2 batches manufactured by Naprod Life Science Pvt. Ltd (Maharashtra) were declared Not of Standard Quality in November 2023. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.
Most recent flagged batch: NN3139A, Methotrexate Injection IP 25 mg / ml (MEREX 1000) (exp Feb 2025). CDL Kolkata (CDSCO lab) found it not of standard quality: Sterility & Bacterial endotoxins. Listed in the November 2023 alert.
Records by type
2 records linked to Naprod Life Science Pvt. Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.
CDSCO drug alerts: Not of Standard Quality and spurious drugs
Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.
Flagged batches per year
All flagged batches
| Product | Batch | Reason declared NSQ | Tested by | Alert |
|---|---|---|---|---|
| Methotrexate Injection IP 25 mg / ml (MEREX 1000) | Batch NN3139AMfg Mar 2023 · Exp Feb 2025 | Sterility & Bacterial endotoxinsSterility | CDL KolkataCDSCO lab | Nov 2023 |
| Methotrexate Injection IP 25 mg / ml (MEREX 1000) | Batch NN3188AMfg Apr 2023 · Exp Mar 2025 | SterilitySterility | CDL KolkataCDSCO lab | Nov 2023 |
Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.